Needle-Free hope: new shot delivery may ease myeloma treatment
NCT ID NCT05704049
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug combination (isatuximab, carfilzomib, and dexamethasone) given under the skin to adults whose multiple myeloma has returned or stopped responding to prior treatments. The main goal is to see how well the cancer responds and to compare two ways of giving the shot: by hand or using a wearable device. About 118 participants will be enrolled, and the study is currently active but no longer recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinica São Germano- Site Number : 0760003
São Paulo, 04537-080, Brazil
-
Hospital Mae de Deus Site Number : 0760002
Porto Alegre, Rio Grande do Sul, 90880-480, Brazil
-
Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo- Site Number : 0760001
São Paulo, 05403-000, Brazil
-
Investigational Site Number : 0360001
Melbourne, Victoria, 3065, Australia
-
Investigational Site Number : 0360002
Wollongong, New South Wales, 2500, Australia
-
Investigational Site Number : 1560001
Tianjin, 300020, China
-
Investigational Site Number : 1560002
Guangzhou, 510060, China
-
Investigational Site Number : 1560003
Wuhan, 430030, China
-
Investigational Site Number : 1560004
Shenyang, 110004, China
-
Investigational Site Number : 1560005
Nanchang, 330006, China
-
Investigational Site Number : 1560006
Changsha, 410013, China
-
Investigational Site Number : 1560007
Tianjin, 300060, China
-
Investigational Site Number : 2030001
Prague, 128 08, Czechia
-
Investigational Site Number : 2030002
Brno, 625 00, Czechia
-
Investigational Site Number : 2030003
Ostrava, 708 52, Czechia
-
Investigational Site Number : 2030004
Olomouc, 779 00, Czechia
-
Investigational Site Number : 3000001
Athens, 106 76, Greece
-
Investigational Site Number : 3000002
Athens, 115 28, Greece
-
Investigational Site Number : 3920001
Kashiwa, Chiba, 277-8577, Japan
-
Investigational Site Number : 3920002
Okayama, 701-1192, Japan
-
Investigational Site Number : 6200001
Braga, 4710-243, Portugal
-
Investigational Site Number : 6200004
Lisbon, 1400-038, Portugal
-
Investigational Site Number : 6200005
Lisbon, 1649-035, Portugal